Related Experiment Video
Updated: Apr 18, 2026

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo
Published on: February 6, 2015
Evaluation of chemoresponse assays as predictive markers
1Biometric Research Branch, MSC 9735, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD 20892, USA.
Evaluating chemoresponse assays is challenging. New analytic methods may incorrectly suggest an assay is predictive, even when it has no predictive ability.
Area of Science:
- Oncology
- Biostatistics
- Medical Diagnostics
Background:
- Chemoresponse assays aim to predict patient drug response for personalized treatment.
- Accurate prediction of treatment efficacy is crucial in oncology.
- Two novel analytic methods for assessing chemoresponse assay predictivity have been introduced.
Purpose of the Study:
- To evaluate the performance of newly proposed analytic methods for chemoresponse assays.
- To identify potential limitations in assessing the predictive value of chemoresponse assays.
Main Methods:
- The study considered three hypothetical examples where a chemoresponse assay lacks predictive ability.
- These examples were used to test the properties of the analytic methods proposed by Tian et al.
Main Results:
- The proposed analytic methods incorrectly indicated predictive ability in all three tested examples.
- This suggests a potential flaw in the methods when applied to assays without true predictive power.
Conclusions:
- Evaluating the predictive value of chemoresponse assays presents significant challenges.
- The findings highlight the need for careful validation of analytic methods used in chemoresponse assay assessment.
More Related Videos
08:04In Vitro Tumor Cell Rechallenge For Predictive Evaluation of Chimeric Antigen Receptor T Cell Antitumor Function
Published on: February 27, 2019
09:41An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells
Published on: July 15, 2015